Zürcher Nachrichten - MicroVision Announces Third Quarter 2025 Results

EUR -
AED 4.35335
AFN 77.050797
ALL 96.614026
AMD 452.873985
ANG 2.121943
AOA 1087.00321
ARS 1723.800654
AUD 1.702936
AWG 2.136666
AZN 2.019869
BAM 1.955248
BBD 2.406031
BDT 145.978765
BGN 1.990709
BHD 0.449191
BIF 3539.115218
BMD 1.18539
BND 1.512879
BOB 8.254703
BRL 6.231008
BSD 1.194568
BTN 109.699013
BWP 15.630651
BYN 3.402439
BYR 23233.647084
BZD 2.402531
CAD 1.615035
CDF 2684.909135
CHF 0.915881
CLF 0.026011
CLP 1027.058063
CNY 8.240537
CNH 8.248946
COP 4354.94563
CRC 591.535401
CUC 1.18539
CUP 31.412839
CVE 110.234327
CZK 24.334287
DJF 212.720809
DKK 7.470097
DOP 74.383698
DZD 153.702477
EGP 55.903178
ERN 17.780852
ETB 185.572763
FJD 2.613371
FKP 0.863571
GBP 0.865754
GEL 3.194674
GGP 0.863571
GHS 12.974143
GIP 0.863571
GMD 86.533903
GNF 10372.164298
GTQ 9.16245
GYD 249.920458
HKD 9.257838
HNL 31.365884
HRK 7.536597
HTG 156.336498
HUF 381.328619
IDR 19883.141804
ILS 3.663335
IMP 0.863571
INR 108.679593
IQD 1553.453801
IRR 49934.560565
ISK 144.985527
JEP 0.863571
JMD 187.197911
JOD 0.840489
JPY 183.433247
KES 152.915746
KGS 103.662825
KHR 4768.236408
KMF 491.93733
KPW 1066.928941
KRW 1719.752641
KWD 0.36382
KYD 0.995519
KZT 600.800289
LAK 25485.888797
LBP 101410.128375
LKR 369.427204
LRD 219.593979
LSL 19.132649
LTL 3.500149
LVL 0.717031
LYD 7.495914
MAD 10.835985
MDL 20.092409
MGA 5260.173275
MKD 61.631889
MMK 2489.287708
MNT 4228.659246
MOP 9.606327
MRU 47.30937
MUR 53.852723
MVR 18.32658
MWK 2059.023112
MXN 20.70407
MYR 4.672854
MZN 75.580924
NAD 18.967522
NGN 1643.520192
NIO 43.508231
NOK 11.437875
NPR 175.519161
NZD 1.96876
OMR 0.458133
PAB 1.194573
PEN 3.994177
PGK 5.066955
PHP 69.837307
PKR 331.998194
PLN 4.215189
PYG 8001.773454
QAR 4.316051
RON 5.097064
RSD 117.111851
RUB 90.544129
RWF 1742.915022
SAR 4.446506
SBD 9.544303
SCR 17.200951
SDG 713.016537
SEK 10.580086
SGD 1.505332
SHP 0.88935
SLE 28.834661
SLL 24857.038036
SOS 677.454816
SRD 45.104693
STD 24535.182964
STN 24.493185
SVC 10.452048
SYP 13109.911225
SZL 19.132635
THB 37.411351
TJS 11.151397
TMT 4.148866
TND 3.37248
TOP 2.854135
TRY 51.47818
TTD 8.110743
TWD 37.456003
TZS 3052.380052
UAH 51.199753
UGX 4270.811618
USD 1.18539
UYU 46.357101
UZS 14603.874776
VES 410.075543
VND 30749.020682
VUV 141.680176
WST 3.213481
XAF 655.774526
XAG 0.014004
XAU 0.000244
XCD 3.203577
XCG 2.153028
XDR 0.815573
XOF 655.774526
XPF 119.331742
YER 282.508153
ZAR 19.136335
ZMK 10669.938133
ZMW 23.443477
ZWL 381.695147
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    1.3800

    83.78

    +1.65%

  • CMSD

    -0.0400

    24.05

    -0.17%

  • JRI

    0.1400

    13.08

    +1.07%

  • RELX

    -0.3700

    35.8

    -1.03%

  • BCC

    0.5100

    80.81

    +0.63%

  • RIO

    -4.1000

    91.03

    -4.5%

  • BCE

    0.3700

    25.86

    +1.43%

  • AZN

    0.1800

    92.77

    +0.19%

  • CMSC

    0.0500

    23.76

    +0.21%

  • BTI

    0.4600

    60.68

    +0.76%

  • VOD

    -0.0600

    14.65

    -0.41%

  • NGG

    0.2000

    85.27

    +0.23%

  • RYCEF

    -0.4300

    16

    -2.69%

  • BP

    -0.1600

    37.88

    -0.42%

  • GSK

    0.9400

    51.6

    +1.82%

MicroVision Announces Third Quarter 2025 Results
MicroVision Announces Third Quarter 2025 Results

MicroVision Announces Third Quarter 2025 Results

REDMOND, WASHINGTON / ACCESS Newswire / November 11, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced its third quarter 2025 results.

Text size:

Key Business and Operational Highlights

  • Appointed 30-year industry veteran Glen DeVos as Chief Executive Officer, elevating automotive capabilities.

  • Introduced next generation solid-state lidar sensor, MOVIA S, offering an energy-efficient and cost-effective short-range solution for a wide variety of automotive, industrial, and defense sector applications.

  • Launched industry-disrupting Tri-Lidar Architecture solution, offering an alternative to the lidar industry's myopic focus on single sensor solutions.

  • Executed agreement to acquire Scantinel Photonics, a German developer of long-range FMCW lidar, joining investment and strategic partners in advancing lidar-on-chip solution for commercial vehicle and passenger car markets.

  • Established design office and testing facilities in D.C. area, with engineering expertise in aviation and avionics, accelerating development and time-to-market in defense sector, focused on intelligence, surveillance, and reconnaissance, or ISR, capabilities.

  • Expanded global sales and engineering leadership, bringing decades of experience to sales organization and commercialization discipline.

  • Maintained strong balance sheet, cost-efficient operations, and sound financial practices.

"I've been thrilled to see the Company's momentum and energy these past six weeks, as I stepped into my new role here at MicroVision," said Glen DeVos, MicroVision's Chief Executive Officer. "The Company is making great strides - processing the high level of external interest stemming from the unveiling at IAA Mobility of our next-gen short-range sensor; optimizing perception system value to automotive OEMs by disrupting norms to offer a cost-effective, integrated solution; accelerating our drone-agnostic perception solution and expansion into ISR applications; and collaborating with the EU's photonics ecosystem to bring 1550nm FMCW lidar technology to the commercial vehicle and passenger car markets."

"Based on my experience in the evolution of radar, I'm confident that MicroVision will be a leader in lidar, driving the market to a similar inflection point as we saw when radar became a standard feature in automotive ADAS," continued DeVos. "MicroVision has the product portfolio, engineering excellence, and strategic plan to disrupt the market and I am thrilled to lead MicroVision as we redefine the future of lidar."

Key Financial Highlights for Q3 2025

  • Revenue for the third quarter of 2025 was $0.2 million, flat compared to $0.2 million for the third quarter of 2024, comprised of sales to industrial customers.

  • Total operating expenses for the third quarter of 2025 were $12.0 million, which, after adjusting for non-cash items, remained relatively flat year over year as compared to $15.3 million for the third quarter of 2024.

  • Net loss for the third quarter of 2025 was $14.2 million, or $0.05 per share, which includes $2.2 million of non-cash interest expense related to financings, $1.2 million of severance payments related to CEO transition, $0.7 million related to non-cash unrealized gains on warrants and derivatives, and a negative $1.6 million of non-cash share-based compensation expense (which was negative due to the reversal of expense in connection with the forfeiture of certain executive awards in the period), compared to a net loss of $15.5 million, or $0.07 per share, which includes $2.4 million of non-cash share-based compensation expense for the third quarter of 2024.

  • Adjusted EBITDA for the third quarter of 2025 was a $11.7 million loss, flat compared to a $11.7 million loss for the third quarter of 2024.

  • Cash used in operations in the third quarter of 2025 was $16.5 million, compared to cash used in operations in the third quarter of 2024 of $14.1 million.

  • The Company ended the third quarter of 2025 with $99.5 million in cash and cash equivalents, including investment securities, compared to $74.7 million as of December 31, 2024.

As of September 30, 2025, the Company has access to $76.2 million of additional capital, subject to certain conditions, including $46.2 million under its existing ATM, or at-the-market, facility and $30 million from the remaining commitment pursuant to the convertible note facility.

Conference Call and Webcast: Q3 2025 Results

MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Tuesday, November 11, 2025 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on November 11, 2025 and may submit questions HERE in advance of the conference call.

The live webcast can be accessed on the Company's Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing.

About MicroVision

MicroVision is at the forefront of driving the global adoption of innovative perception solutions, with the goal of making mobility and autonomy safer. Our engineering excellence, based in Washington State, Washington D.C., and Hamburg, Germany enables us to develop and supply integrated lidar hardware and perception software solutions. Our proprietary technologies enhance safety and automation across various industrial applications, including robotics, automated warehouses, and agriculture, and are instrumental in the development of autonomous systems. MicroVision's core technology, initially developed for the automotive industry, continues to accelerate advanced driver-assistance systems (ADAS) and autonomous driving. Building on our history of providing technology to the military segment, our target offerings include semi- and fully autonomous airborne and terrestrial sensor systems. With our solid-state lidar technologies, encompassing MEMS-based long-range lidar and flash-based short-range lidar, integrated with our onboard perception software, MicroVision possesses the expertise to deliver safe mobility at the speed of life.

For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP information

To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; and restructuring costs. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.

Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking Statements

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for revenue and cash; expense reduction; market position; product portfolio; product and manufacturing capabilities; transaction benefits, conditions, and expected completion; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact
Jeff Christensen
Darrow Associates Investor Relations
[email protected]

Media Contact
[email protected]

MicroVision, Inc.
Consolidated Balance Sheets
(In thousands)

September 30,

December 31,

2025

2024

Assets
Current assets
Cash and cash equivalents

$

72,832

$

54,486

Investment securities, available-for-sale

26,676

20,216

Restricted cash, current

328

261

Accounts receivable, net of allowances

40

926

Inventory

8,131

2,294

Other current assets

6,969

4,287

Total current assets

114,976

82,470

Property and equipment, net

6,574

7,061

Operating lease right-of-use assets

15,365

16,746

Restricted cash, net of current portion

1,374

1,500

Intangible assets, net

10,281

10,972

Other assets

2,252

2,412

Total assets

$

150,822

$

121,161

Liabilities and shareholders' equity
Current liabilities
Accounts payable

$

1,339

$

1,132

Accrued liabilities

3,754

2,542

Contract liabilities

147

308

Derivative liability

1,856

14,581

Notes payable, current

28,963

24,248

Operating lease liabilities, current

3,154

2,682

Finance lease liabilities, current

14

-

Other current liabilities

672

458

Total current liabilities

39,899

45,951

Notes payable, net of current portion

-

8,754

Warrant liability

4,059

-

Operating lease liabilities, net of current portion

14,434

15,954

Finance lease liabilities, net of current portion

31

-

Other long-term liabilities

1,680

1,733

Total liabilities

60,103

72,392

Commitments and contingencies
Shareholders' equity
Common stock at par value

302

225

Additional paid-in capital

1,009,272

910,825

Accumulated other comprehensive income

651

-

Accumulated deficit

(919,506

)

(862,281

)

Total shareholders' equity

90,719

48,769

Total liabilities and shareholders' equity

$

150,822

$

121,161

MicroVision, Inc.
Consolidated Statement of Operations
(In thousands, except per share data)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Revenue

$

241

$

190

$

985

$

3,046

Cost of revenue

957

583

2,223

3,414

Gross loss

(716

)

(393

)

(1,238

)

(368

)

Research and development expense

7,978

8,736

23,039

40,251

Sales, marketing, general and administrative expense

4,027

6,599

17,140

23,423

Impairment loss on intangible assets

-

-

-

3,027

Gain on disposal of fixed assets

-

(22

)

-

(22

)

Total operating expenses

12,005

15,313

40,179

66,679

Loss from operations

(12,721

)

(15,706

)

(41,417

)

(67,047

)

Interest expense

(2,197

)

(21

)

(17,270

)

(51

)

Unrealized gain on derivative liability

1,059

-

3,853

-

Unrealized (loss) gain on warrant liability

(326

)

-

2,238

-

Realized loss on debt extinguishment

-

-

(4,654

)

-

Other income

140

318

363

1,764

Net loss before taxes

$

(14,045

)

$

(15,409

)

$

(56,887

)

$

(65,334

)

Income tax expense

(172

)

(108

)

(338

)

(426

)

Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Net loss per share - basic and diluted

(0.05

)

$

(0.07

)

$

(0.22

)

$

(0.32

)

Weighted-average shares outstanding - basic and diluted

295,461

213,004

262,235

206,164

MicroVision, Inc.
Consolidated Statements of Cash Flows
(In thousands)

Nine months ended September 30,

2025

2024

Cash flows from operating activities
Net loss

$

(57,225

)

$

(65,760

)

Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization

4,347

5,246

Gain on disposal of fixed assets

-

(22

)

Impairment of intangible assets

-

3,027

Impairment of operating lease right-of-use assets

-

406

Unrealized gain on derivative liability

(3,853

)

-

Unrealized gain on warrant liability

(2,238

)

-

Loss on debt extinguishment

4,654

-

Inventory write-downs

-

127

Non-cash interest expense

7,325

-

Amortization of debt discount and issuance costs on notes payable

9,915

-

Share-based compensation expense

2,248

9,522

Net accretion of premium on short-term investments

(284

)

(776

)

Change in:
Accounts receivable

886

717

Inventory

(5,798

)

(723

)

Other current and non-current assets

(2,170

)

606

Accounts payable

207

(784

)

Accrued liabilities

1,087

(2,747

)

Contract liabilities and other current liabilities

32

109

Operating lease liabilities

(2,188

)

(1,944

)

Other long-term liabilities

(260

)

(488

)

Net cash used in operating activities

(43,315

)

(53,484

)

Cash flows from investing activities
Sales of investment securities

26,688

28,311

Purchases of investment securities

(32,878

)

(25,570

)

Purchases of property and equipment

(435

)

(271

)

Cash paid for Ibeo business combination

-

(6,300

)

Net cash used in investing activities

(6,625

)

(3,830

)

Cash flows from financing activities
Principal payments under finance leases

(10

)

-

Principal payments under notes payable

(5,500

)

-

Proceeds from stock option exercises

-

62

Net proceeds from issuance of common stock and warrants

73,268

26,093

Net cash provided by financing activities

67,758

26,155

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

469

133

Change in cash, cash equivalents, and restricted cash

18,287

(31,026

)

Cash, cash equivalents, and restricted cash at beginning of period

56,247

49,391

Cash, cash equivalents, and restricted cash at end of period

$

74,534

$

18,365

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2025 and 2024:

September 30,

September 30,

2025

2024

Cash and cash equivalents

$

72,832

$

16,523

Restricted cash, current

328

270

Restricted cash, net of current portion

1,374

1,572

Cash, cash equivalents, and restricted cash

$

74,534

$

18,365

MicroVision, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Reconciliation of Non-GAAP Gross (Loss) Profit:
Gross loss

$

(716

)

$

(393

)

$

(1,238

)

$

(368

)

Share-based compensation expense

-

-

-

-

Amortization of acquired intangibles

290

361

652

1,135

Adjusted Gross (Loss) Profit

$

(426

)

$

(32

)

$

(586

)

$

767

Reconciliation of Non-GAAP Loss:
GAAP Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Interest expense, net

2,057

(462

)

16,907

(1,570

)

Income taxes

172

108

338

426

Depreciation and amortization

1,395

1,676

4,347

5,246

Unrealized gain on derivative liability

(1,059

)

-

(3,853

)

-

Unrealized loss (gain) warrant liability

326

-

(2,238

)

-

Loss on debt extinguishment

-

-

4,654

-

Impairment loss on intangible assets

-

-

-

3,027

Impairment of operating lease right-of-use assets

-

13

-

406

Share-based compensation expense

(1,603

)

2,426

2,248

9,522

Restructuring costs

-

90

-

5,804

Severance expense

1,202

-

1,202

-

Adjusted EBITDA

$

(11,727

)

$

(11,666

)

$

(33,620

)

$

(42,899

)

SOURCE: MicroVision, Inc



View the original press release on ACCESS Newswire

T.Furrer--NZN